Bazarbashi, S., Aljubran, A., Alzahrani, A., Mohieldin, A., Soudy, H., & Shoukri, M. (2015). Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer. Cancer Med.

Bazarbashi, Shouki, Ali Aljubran, Ahmad Alzahrani, Ahmed Mohieldin, Hussein Soudy, and Mohammed Shoukri. "Phase I/II Trial of Capecitabine, Oxaliplatin, and Irinotecan in Combination With Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer." Cancer Med 2015.

Bazarbashi, Shouki, et al. "Phase I/II Trial of Capecitabine, Oxaliplatin, and Irinotecan in Combination With Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer." Cancer Med 2015.